| Product NDC: | 0069-4220 |
| Proprietary Name: | Viagra |
| Non Proprietary Name: | sildenafil citrate |
| Active Ingredient(s): | 100 mg/1 & nbsp; sildenafil citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0069-4220 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020895 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980327 |
| Package NDC: | 0069-4220-66 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0069-4220-66) |
| NDC Code | 0069-4220-66 |
| Proprietary Name | Viagra |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0069-4220-66) |
| Product NDC | 0069-4220 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sildenafil citrate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19980327 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | SILDENAFIL CITRATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |